Target intelligence / Profile preview

UDP-Gal:betaGlcNAc beta-1,3-galactosyltransferase, polypeptide 3 pseudogene

Molecular classification
Other (Pseudogene)
01

Overview

This entry denotes a pseudogene corresponding to the beta-1,3-galactosyltransferase 3 gene family, which codes for non-functional genomic DNA sequences similar in structure to active galactosyltransferase genes. Unlike its functional paralogs, it does not encode a protein product, is not implicated in catalytic activity, and does not function as a druggable target. Key distinctions: - The functional family members (e.g., B3GALT1, B3GALT2) synthesize glycan chains in glycoproteins and glycolipids, playing roles in cell–cell recognition and possibly in disease[1][2]. - Pseudogenes like the one described here are productless remnants of gene duplication or retrotransposition events and do not participate in these processes. Summary: This target is a non-functional, non-coding pseudogene and is not a receptor, enzyme, or other druggable protein. No aliases, functions, disease roles, or drug interactions applicable. Any attempt to use this as a therapeutic target or experimental receptor would be incorrect based on current genomic annotation. If you were instead seeking information about a functional beta-1,3-galactosyltransferase, such as B3GALT1 or B3GALT2, those are enzymes involved in glycan biosynthesis and may have biological and disease significance[1][2][4]. This is NOT the case for ENSG00000225711.

Other names
B3GALT3PB3GALT3 pseudogenebeta-1,3-galactosyltransferase 3 pseudogene

Beyond the preview

Go deeper on UDP-Gal:betaGlcNAc beta-1,3-galactosyltransferase, polypeptide 3 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UDP-Gal:betaGlcNAc beta-1,3-galactosyltransferase, polypeptide 3 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call